• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Jazz Pharmaceuticals Plc

+ Add to Watchlist


136.1550 USD 0.0550 0.04%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Jazz Pharmaceuticals Plc (JAZZ)

Open: 137.8600 Day's Range: 134.0400 - 140.4400 Volume: 1,066,653
Previous Close: 136.1000 52wk Range: 53.2900 - 176.6010 1-Yr Rtn: +148.91%

Stock Chart for JAZZ

No chart data available.
  • JAZZ:US 136.1550
  • 1D
  • 1M
  • 1Y
Interactive JAZZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JAZZ

Current P/E Ratio (ttm) 35.3235
Estimated P/E(12/2014) 16.6286
Relative P/E vs. SPX 2.0568
Earnings Per Share (USD) (ttm) 3.8545
Est. EPS (USD) (12/2014) 8.1880
Est. PEG Ratio 0.8470
Market Cap (M USD) 8,105.05
Shares Outstanding (M) 59.53
30 Day Average Volume 1,277,954
Price/Book (mrq) 6.0802
Price/Sale (ttm) 9.0957
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JAZZ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for JAZZ

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Bruce C CozaddChairman/CEO/Co-FounderSeamus C MulliganChief Business Officer
Russell J CoxExec VP/Chief Commercial OfcrSuzanne Sawochka HooperExec VP/General Counsel
More Company Profile & Key Executives for JAZZ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil